B2B ad examples

Every unnecessary preparation step creates additional workload. Pre-assembled blood collection configurations can help save time and reduce manual assembly steps that may introduce needle stick injury risks. 💡Learn more: https://lnkd.in/dMHEasDk

Los profesionales sanitarios nunca deberían tener que elegir entre la seguridad y la comodidad del paciente. Un dispositivo adecuado para la toma de muestras de sangre puede ayudar a conseguir ambas cosas. 💡 Más información sobre las Palomillas de SEGURIDAD VACUETTE®: https://lnkd.in/dFheuAB7

CMOs at health brands: Elpida ClinicalTrust shows how AI assistants answer about your category and where your brand is missing.

Telehealth growth leads: Elpida ClinicalTrust checks whether AI assistants can read your services, prices and booking pages.

⏳ 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗔𝗿𝗲 𝗦𝘁𝗶𝗹𝗹 𝗢𝗽𝗲𝗻 — 𝗔𝗽𝗽𝗹𝘆 𝗯𝘆 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟲! Driving innovation at the intersection of AI and Life Sciences? Whether you're advancing AI-driven drug discovery, engineering next-generation biologics, or developing innovative AI-powered platforms, 𝘁𝗵𝗶𝘀 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝘁𝗮𝗸𝗲 𝘆𝗼𝘂𝗿 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝘁𝗵𝗲 𝘀𝘁𝗮𝗴𝗲! 🌟 𝗪𝗵𝘆 𝗔𝗽𝗽𝗹𝘆? 🎤 𝗣𝗶𝘁𝗰𝗵 𝗼𝗻 𝗦𝘁𝗮𝗴𝗲 – Showcase your innovation to industry leaders and investors during JPM Week 2027. 🏆 𝗖𝗼𝗺𝗽𝗲𝘁𝗲 𝗳𝗼𝗿 𝗔𝘄𝗮𝗿𝗱𝘀 – Get a chance to win GenScript and NVIDIA credits. 🤝 𝗕𝘂𝗶𝗹𝗱 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻𝘀 – Connect with the GenScript and NVIDIA ecosystems and explore new opportunities. 📅 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲: November 6, 2026 📍 𝗣𝗶𝘁𝗰𝗵 𝗗𝗮𝘆: January 13, 2027 | San Francisco, CA Don't miss your chance to pitch during JPM Week 2027!

AI is changing more than the science of drug discovery. At the 𝟮𝟬𝟮𝟲 𝗚𝗲𝗻𝗦𝗰𝗿𝗶𝗽𝘁 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗼𝗿𝘂𝗺 – 𝗟𝗼𝗻𝗱𝗼𝗻 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗥𝗲𝗰𝗲𝗽𝘁𝗶𝗼𝗻, we look forward to exploring how AI is reshaping how conviction is built, how opportunities are evaluated, and where capital moves next. On 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟳𝘁𝗵, alongside the 𝗝𝗲𝗳𝗳𝗲𝗿𝗶𝗲𝘀 𝗟𝗼𝗻𝗱𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, GenScript will bring together leaders across AI, biotech, and capital for an exclusive executive conversation in London. At the center of the evening: a fireside discussion exploring how AI is influencing therapeutic innovation, investment decisions, and the future of the biotech ecosystem. A focused conversation among the people shaping what comes next in biotech. Click below to RSVP now.

Stark gegen Bakterien. Gewebefreundlicher als PVP-I. Antimikrobielle Wirksamkeit und Gewebefreundlichkeit müssen kein Widerspruch sein. PREVENTIA® Surgical Irrigation bietet 99,99 % Bakterienreduktion in 1 Minute und ist gleichzeitig gewebefreundlicher als PVP-I. Eine starke Balance für die chirurgische Wundspülung. PREVENTIA® Surgical Irrigation. Wirksamkeit trifft Gewebefreundlichkeit.

How do you find out a CNA is about to leave? For most facilities, it's the resignation. 40% of care staff leave in their first 100 days, right when visibility is lowest. Retain surveys new hires at 15, 30, 60, and 90 days and flags who's at risk while there's still a window to act.

Turnover now touches your Medicare payment. Starting in 2026, Total Nursing Staff Turnover is one of four measures in SNF Value-Based Purchasing. Retain checks in with new hires at 15, 30, 60, and 90 days and alerts their manager when someone is at risk, so you have time to act.

When every second counts, the new LOGIQ™ e X delivers console-quality imaging in a portable, laptop-sized system. Built for emergency medicine with AI-powered tools, advanced imaging and workflow innovations for fast-paced care environments.

Das bringst du mit: 🎯 HR-Expertise: Fundierte Erfahrung in der operativen Personalarbeit. 💻 System-Kenntnisse: Sicherer Umgang mit Fidelis (das ist für uns ein absolutes Must-have!). 🤝 Persönlichkeit: Du bist kommunikationsstark, serviceorientiert und ein echter Teamplayer. Jetzt bewerben!

💼 Neuer Job in Troisdorf: Wir suchen dich als Personalreferent (m/w/d)! 🚀 Du liebst HR, behältst auch bei der Entgeltabrechnung den vollen Durchblick und Fidelis ist für dich kein Fremdwort, sondern dein täglich Brot? Dann haben wir das perfekte Match für dich! Für unser Team in Troisdorf suchen wir Verstärkung im Personalwesen. Bei uns erwarten dich abwechslungsreiche Aufgaben, ein tolles Team und echter Gestaltungsspielraum.

Portable, laptop-sized premium ultrasound for anesthesia. The new LOGIQ™ e X combines console-quality imaging, AI-powered tools and workflow innovations across perioperative care, pain management, emergency medicine and critical care.

🩺 ABC Lekarza Rodzinnego powraca z IV edycją! Aktualna wiedza, praktyczne wskazówki, dyskusja o tym, co naprawdę ważne w codziennej praktyce lekarza rodzinnego. Do zobaczenia podczas jesiennej edycji ABC Lekarza Rodzinnego! 📅 18 listopada 2026 r. o godz. 18:30 W programie webinaru: 🔹 Trzy proste kroki do eutyreozy - TSH pod lupą lekarza praktyka 🔹 Serce zna ten rytm już od 40 lat – jaki powinien być optymalny HR. 🔹 Sztafeta pokoleń - czego młodzi uczą się od starszych, a starsi od młodszych? 🎓 Dołącz do spotkania z ekspertami, poznaj ich perspektywę i weź udział w sesji pytań i odpowiedzi. 👉 Zarejestruj się już dziś!

"Non-malignant" is a clinical term. It's not how patients experience it. Desmoid tumors, TGCT and NF1-PN can shape a life for decades, through pain, lost function and recurrence. We're committed to the outcomes that matter in real life: function, quality of life and long-term disease control.

At Galderma, patient safety sits at the heart of how we advance dermatology. We’re looking for an experienced Global PV Risk Minimisation Physician to provide medical leadership across our Injectable Aesthetics medical device portfolio in Uppsala, Sweden. Bring your expertise in medical device vigilance, benefit-risk assessment, signal detection and risk minimisation to help shape global safety strategies, support regulatory decisions and influence product lifecycle management. Bring your expertise. Make a direct impact. Advance dermatology with Galderma. #GaldermaCareers #MakeADirectImpact #AdvancingDermatology

Join Benqian Wei from Merck for our next GenovisWebinar: Advancing Biotherapeutic Characterization – HILIC-MS-Enabled Subunit-Level MAM. Benqian will show how FabRICATOR® subunit digestion combined with HILIC-MS improves separation and monitoring of critical PQAs in complex biotherapeutics – with case studies on IgG and Fc-fusion proteins. Relevant for analytical scientists, MS-based MAM in R&D and QC, CROs, and lab heads optimizing PQA monitoring. 📅 Thursday Nov 12 | 10 AM ET / 4 PM CET

𝐕𝐞𝐫𝐩𝐥𝐞𝐞𝐠𝐤𝐮𝐧𝐝𝐢𝐠𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐱𝐞 𝐆𝐆𝐙 𝐉𝐢𝐣 𝐳𝐢𝐞𝐭 𝐝𝐞 𝐦𝐞𝐧𝐬 𝐚𝐜𝐡𝐭𝐞𝐫 𝐝𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐞𝐢𝐭.💚 Als verpleegkundige in de complexe GGZ kijk je verder dan de diagnose. Je combineert verpleegkundige zorg met persoonlijke begeleiding en helpt cliënten grip, vertrouwen en perspectief te vinden. Juist wanneer het ingewikkeld wordt, maak jij het verschil. 🌿 𝐁𝐢𝐣 𝐇𝐮𝐢𝐳𝐞 𝐏𝐚𝐝𝐮𝐚 𝐢𝐧 𝐁𝐨𝐞𝐤𝐞𝐥 werk je in een groene, levendige omgeving met verschillende expertises. Je krijgt de kans om je te verdiepen in een doelgroep die bij jouw talenten past. Samen met collega's en behandelaren blijf je nieuwsgierig, durf je nieuwe wegen te verkennen en zet je jouw kennis daadkrachtig in. Want goede zorg ontstaat door verbinding. Ben jij BIG-geregistreerd verpleegkundige en toe aan werk waarin jouw vakmanschap én jouw blik op de mens ertoe doen? 👉𝐎𝐧𝐭𝐝𝐞𝐤 𝐣𝐨𝐮𝐰 𝐦𝐨𝐠𝐞𝐥𝐢𝐣𝐤𝐡𝐞𝐝𝐞𝐧 𝐛𝐢𝐣 𝐇𝐮𝐢𝐳𝐞 𝐏𝐚𝐝𝐮𝐚 𝐚𝐥𝐬 𝐯𝐞𝐫𝐩𝐥𝐞𝐞𝐠𝐤𝐮𝐧𝐝𝐢𝐠𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐱𝐞 𝐆𝐆𝐙: https://dlrs.info/Ddr1Zi6 GGZ Oost Brabant. Het is zo gek nog niet, om het samen te doen.

How much time does your team spend adapting content that already exists? Making global content available is a start. The value comes when local teams can find it, adapt it and reuse it easily, saving time and reducing repeated production work. In this excerpt from our recent webinar with MarketBeam, our CEO Maurice van Leeuwen explores what gets in the way of making content reuse work in practice. What does that look like in your organisation? Our Content Excellence Quick Scan helps you reflect on your current approach and identify opportunities to make content reuse easier. Take the scan → https://lnkd.in/dex93riG #ContentExcellence #PharmaMarketing #ContentReuse

🔬 Same programme. Different responses. Why do older adults respond differently to the same exercise training programme? A new study published in the European Journal of Applied Physiology explores how individual factors influence improvements in muscle strength and physical performance following a 12-month training programme. The research, involving 288 older adults, found significant improvements in muscle strength and walking performance, while highlighting considerable differences in how individuals responded to training. 💡Key finding: Greater adherence to resistance training was associated with higher responsiveness across multiple physical outcomes. HUR’s air-pressure resistance training equipment and SmartTouch technology were used in the study’s training programme. We sincerely thank our research partners for their valuable work and continued contribution to advancing scientific knowledge in healthy ageing. 📖 Read the open-access study: https://lnkd.in/dCUX7mz7 #HUR #HealthyAgeing #StrengthTraining #ActiveAgeing #Research #EvidenceBasedExercise

File d'attente, téléphone qui sonne, tâches administratives… et au milieu, un patient qui attend votre conseil. Et si l'IA vous aidait à revenir à l'essentiel ? Dans notre livre blanc gratuit, découvrez : ✅ ce que l'IA est (et n'est pas) ✅ la différence entre IA de confiance et IA grand public ✅ des cas d'usage déjà concrets en officine ✅ les bonnes pratiques pour protéger les données de santé de vos patients ✅ une fiche de suivi pour mesurer les bénéfices de l'IA 📘 Téléchargez-le gratuitement.

Oak Creek needs experienced nurses. Find day and night RN roles at Froedtert Community Hospital - Oak Creek at FroedtertJobs.com.

𝗛𝗔𝗟 𝗔𝗹𝗹𝗲𝗿𝗴𝘆 𝗲𝗻𝗿𝗼𝗹𝗹𝘀 𝗳𝗶𝗿𝘀𝘁 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁 𝗶𝗻 𝗻𝗲𝘅𝘁 𝗵𝗼𝘂𝘀𝗲 𝗱𝘂𝘀𝘁 𝗺𝗶𝘁𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 🔬 Following the successful completion of our Phase III study PM/0059, we're taking the next step in our clinical development program for PM50k. With the first patient now enrolled, our Phase II study PM/0062 investigates whether the up-dosing phase of house dust mites allergen immunotherapy (AIT) can be shortened from six injections over five weeks to just three injections over two weeks. The study will evaluate the safety and tolerability of this accelerated schedule in 120 adults across 15 study centers in Germany and Poland. Our goal is to explore how a shorter up-dosing schedule could make AIT more convenient for patients and healthcare professionals. ______________________________ 𝗛𝗔𝗟 𝗔𝗹𝗹𝗲𝗿𝗴𝘆 𝗻𝗶𝗺𝗺𝘁 𝗱𝗲𝗻 𝗲𝗿𝘀𝘁𝗲𝗻 𝗧𝗲𝗶𝗹𝗻𝗲𝗵𝗺𝗲𝗿 𝗶𝗻 𝗱𝗶𝗲 𝗻ä𝗰𝗵𝘀𝘁𝗲 𝗸𝗹𝗶𝗻𝗶𝘀𝗰𝗵𝗲 𝗦𝘁𝘂𝗱𝗶𝗲 𝘇𝘂 𝗛𝗮𝘂𝘀𝘀𝘁𝗮𝘂𝗯𝗺𝗶𝗹𝗯𝗲𝗻 𝗮𝘂𝗳 🔬 Nach dem erfolgreichen Abschluss unserer Phase-III-Studie PM/0059 setzen wir unser klinisches Entwicklungsprogramm für PM50k mit einer weiteren Studie fort. Mit der Aufnahme des ersten Patienten ist unsere Phase-II-Studie PM/0062 gestartet. Sie untersucht, ob sich die Aufdosierungsphase der Allergen-Immuntherapie (AIT) bei Hausstaubmilbenallergie von sechs Injektionen innerhalb von fünf Wochen auf drei Injektionen innerhalb von zwei Wochen verkürzen lässt. An der Studie nehmen insgesamt 120 Erwachsene an 15 Studienzentren in Deutschland und Polen teil. Im Mittelpunkt stehen die Sicherheit und Verträglichkeit des verkürzten Aufdosierungsschemas. Unser Ziel: herauszufinden, ob eine kürzere Aufdosierungsphase die AIT für Patientinnen und Patienten sowie medizinisches Fachpersonal einfacher und alltagstauglicher gestalten könnte.

Days or nights, your next RN role could be at Froedtert Menomonee Falls Hospital. Browse opportunities and apply at FroedtertJobs.com.